Framework agreement for filgotinib tablets

Summary

Amgros I/S is procuring filgotinib tablets in one separately awarded lot under a non-exclusive framework agreement for supply to Danish hospital pharmacies. The estimated quantities are 1,928 units of 100 mg tablets and 21,660 units of 200 mg tablets; actual consumption may differ substantially. The ordinary purchasing period is 1 April–30 September 2027, with options for supply before or after that period and for an extension of up to six months. The estimated value is DKK 39.2 million.